HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KETOCONAZOLE DANDRUFF EFFICACY SUPPORTED BY A "STRONG ASSOCIATION"

This article was originally published in The Rose Sheet

Executive Summary

KETOCONAZOLE DANDRUFF EFFICACY SUPPORTED BY A "STRONG ASSOCIATION" with the reduction of Pityrosporum yeast of the scalp, Janssen Pharmaceutical VP of Medical Affairs Mark Klausner, MD, maintained at a Feb. 16 joint meeting of the Dermatologic Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000171

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel